Cathie Wood Just This Biotech Bet: Reading the Signals
ARKK and ARKG are back in the biotech spotlight as Cathie Wood makes new bets after a setback in a key antisense stoc...
If you’re in your 30s, certain income levels phase out the traditional IRA deduction. This intro explains who qualifies and how to optimize your savings.
16,045 articlesARKK and ARKG are back in the biotech spotlight as Cathie Wood makes new bets after a setback in a key antisense stoc...
Hesai's early 2026 earnings signal a turning point for LiDAR tech adoption. This guide breaks down the Q1 results, wh...
A rising domestic memory player is lining up a major public listing to challenge established DRAM leaders. Investors ...
Bitcoin faces a tough test as ETF outflows converge with rising yields and a global risk-on mood. The phrase bitcoin ...
The Fed is dialed into inflation that won’t quit. Even with cooling CPI numbers, prices stay stubborn in key areas. H...
Big bet shifts by billionaire Michael Platt grab headlines as AI giants face moves from a prominent hedge fund. This ...
Outside money from AIPAC-backed groups totals nearly $30 million in Michigan's Senate primary, testing how much influ...
As AI systems evolve, a watchdog warns 'rogue deployment' risk at top labs. This deep dive explains what rogue deploy...
When headlines shout that berkshire hathaway sold mastercard, investors feel the pull to imitate. This guide explains...
Three Dividend Aristocrats stand out for long-term, reliable passive income. Here's how a $30,000 starter could gener...
When a movie breaks records, it isn’t just a cinephile moment—it’s a chance to rethink how we spend on entertainment....
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...